Liquid Biopsy Market


The global liquid biopsy market is set to experience significant growth, expanding from USD 2.3 billion in 2024 to USD 7.2 billion by 2033, with a compound annual growth rate (CAGR) of 12.82% during the period from 2025 to 2033. This growth is driven by the increasing demand for non-invasive diagnostic techniques that allow for early detection and monitoring of various cancers and other diseases. Liquid biopsies, which analyze circulating tumor cells and cell-free DNA from blood samples, are gaining traction due to their ability to provide real-time insights into a patient's condition without the need for invasive procedures. The rising prevalence of cancer globally, coupled with advancements in genomic technologies and personalized medicine, is further propelling the market.

#marketresearch #business #marketanalysis #markettrends #researchreport #marketreport #marketforecast #marketanalysis #marketgrowth #imarcgroup

Grab a sample pdf: https://www.imarcgroup.com/liquid-biopsy-market